Wolverine Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.8M | Sell |
16,100
-1,600
| -9% | -$1.62M | 0.14% | 149 |
|
|
2025
Q4 | $19M | Buy |
17,700
+2,200
| +14% | +$2.1M | 0.15% | 159 |
|
|
2025
Q3 | $11.8M | Buy |
15,500
+6,600
| +74% | +$4.91M | 0.09% | 217 |
|
|
2025
Q2 | $6.94M | Buy |
8,900
+1,400
| +19% | +$1.09M | 0.06% | 277 |
|
|
2025
Q1 | $6.19M | Buy |
7,500
+4,800
| +178% | +$3.99M | 0.07% | 266 |
|
|
2024
Q4 | $2.08M | Sell |
2,700
-1,100
| -29% | -$911K | 0.02% | 523 |
|
|
2024
Q3 | $3.37M | Sell |
3,800
-9,100
| -71% | -$8.18M | 0.04% | 374 |
|
|
2024
Q2 | $11.7M | Sell |
12,900
-10,100
| -44% | -$8.08M | 0.13% | 174 |
|
|
2024
Q1 | $17.9M | Sell |
23,000
-24,800
| -52% | -$17.6M | 0.2% | 122 |
|
|
2023
Q4 | $27.9M | Buy |
47,800
+30,100
| +170% | +$17.6M | 0.24% | 112 |
|
|
2023
Q3 | $9.51M | Sell |
17,700
-14,600
| -45% | -$7.52M | 0.11% | 206 |
|
|
2023
Q2 | $15.1M | Buy |
32,300
+900
| +3% | +$377K | 0.18% | 133 |
|
|
2023
Q1 | $10.8M | Sell |
31,400
-74,800
| -70% | -$25.2M | 0.13% | 191 |
|
|
2022
Q4 | $38.9M | Buy |
106,200
+93,000
| +705% | +$33M | 0.4% | 60 |
|
|
2022
Q3 | $4.27M | Sell |
13,200
-50,600
| -79% | -$16M | 0.05% | 353 |
|
|
2022
Q2 | $20.7M | Buy |
63,800
+27,100
| +74% | +$8.13M | 0.21% | 135 |
|
|
2022
Q1 | $10.5M | Buy |
36,700
+16,200
| +79% | +$4.17M | 0.1% | 198 |
|
|
2021
Q4 | $5.66M | Buy |
20,500
+15,000
| +273% | +$3.8M | 0.05% | 289 |
|
|
2021
Q3 | $1.27M | Buy |
+5,500
| New | +$1.36M | 0.01% | 646 |
|
|
2017
Q4 | – | Sell |
-25,000
| Closed | -$2.14M | – | 1532 |
|
|
2017
Q3 | $2.14M | Hold |
25,000
| – | – | 0.02% | 470 |
|
|
2017
Q2 | $2.06M | Hold |
25,000
| – | – | 0.03% | 436 |
|
|
2017
Q1 | $2.1M | Hold |
25,000
| – | – | 0.03% | 382 |
|
|
2016
Q4 | $1.84M | Buy |
25,000
+24,300
| +3,471% | +$1.81M | 0.02% | 423 |
|
|
2016
Q3 | $56K | Hold |
700
| – | – | ﹤0.01% | 1035 |
|
|
2016
Q2 | $55K | Buy |
700
+392
| +127% | +$29.5K | ﹤0.01% | 1035 |
|
|
2016
Q1 | $11K | Sell |
308
-131
| -30% | -$9.91K | ﹤0.01% | 1046 |
|
|
2015
Q4 | $421K | Sell |
439
-124
| -22% | -$10.3K | 0.01% | 690 |
|
|
2015
Q3 | $611K | Sell |
563
-406
| -42% | -$34.3K | 0.01% | 631 |
|
|
2015
Q2 | $1.08M | Buy |
969
+10
| +1% | +$762 | 0.02% | 451 |
|
|
2015
Q1 | $402K | Buy |
959
+677
| +240% | +$48.2K | 0.01% | 681 |
|
|
2014
Q4 | $124K | Sell |
282
-27
| -9% | -$1.82K | ﹤0.01% | 1115 |
|
|
2014
Q3 | $181K | Buy |
309
+61
| +25% | +$3.86K | ﹤0.01% | 1100 |
|
|
2014
Q2 | $147K | Buy |
248
+160
| +182% | +$9.55K | ﹤0.01% | 1030 |
|
|
2014
Q1 | $91K | Sell |
88
-420
| -83% | -$23.4K | ﹤0.01% | 1147 |
|
|
2013
Q4 | $17K | Sell |
508
-76
| -13% | -$3.81K | ﹤0.01% | 2115 |
|
|
2013
Q3 | $41K | Sell |
584
-312
| -35% | -$16.3K | ﹤0.01% | 1792 |
|
|
2013
Q2 | $74K | Buy |
+896
| New | +$48.8K | ﹤0.01% | 1536 |
|
Other funds holding LLY
VCM
VPM
Wolverine Asset Management's LLY Position: Q1 2026 in Review
Wolverine Asset Management opened a new position in Eli Lilly (LLY) in Q1 2026: 7,411 shares worth $6.82M. The stake represents 0.07% of the portfolio and ranks #270 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in LLY as recently as Q3 2025.
Wolverine Asset Management first reported a position in LLY in Q2 2013 and has held it in 26 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Wolverine Asset Management held 7,411 shares of Eli Lilly worth $6.82M as of Q1 2026.
- Eli Lilly was a new Wolverine Asset Management position in Q1 2026.
- Eli Lilly made up 0.07% of Wolverine Asset Management's portfolio in Q1 2026, its #270 holding.
- Wolverine Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 26 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.